டெக்லான் தூகண் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டெக்லான் தூகண். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டெக்லான் தூகண் Today - Breaking & Trending Today

Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism


Juvenescence Debuts New Product to Aid in Supporting a Healthy Metabolism
Metabolic Switch helps consumers support their healthy aging goals
News provided by
Share this article
Share this article
DOUGLAS, Isle of Man, April 15, 2021 /PRNewswire/  Juvenescence Ltd. (Juvenescence), a life sciences company focused on modifying aging and increasing human health span and longevity, today announced the launch of its first product. Metabolic Switch is an evidence-based, breakthrough C6 Ketone Di-ester drink that, once consumed, puts the consumer in ketosis to promote a healthy metabolism.
Juvenescence Debuts Metabolic Switch to Aid in Supporting a Healthy Metabolism
Juvenescence Debuts Metabolic Switch to Aid in Supporting a Healthy Metabolism ....

United States , Jim Mellon , Colin Watts , Brianna Stubbs , Declan Doogan , Greg Bailey , Chelsey Fera , Buck Institute For Research On , Juvenescence Ltd , Drug Administration , Buck Institute , Metabolic Syndrome , Related Disorders , Metabolic Switch , Generally Recognized , ஒன்றுபட்டது மாநிலங்களில் , ஜிம் மெலந் , கொலின் வாட்ஸ் , பிரியான்னா ஸ்டப்ப்ஸ் , டெக்லான் தூகண் , கிரெக் பெய்லி , பக் நிறுவனம் க்கு ஆராய்ச்சி ஆன் , பக் நிறுவனம் , வளர்சிதை மாற்ற நோய்க்குறி , தொடர்புடையது கோளாறுகள் , வளர்சிதை மாற்ற சொடுக்கி ,

Juvenescence Limited: Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer


Juvenescence Limited: Juvenescence Appoints Dr. Grazia Piizzi as Chief Scientific Officer
Dr. Grazia Piizzi, PhD, has joined its Executive Management Team as Chief Scientific Officer.
Juvenescence is based on a new understanding of the underlying biological causes of aging, creating evidence-based and science-backed therapies. It is focused on increasing how long people live in health by preventing the diseases of aging in the ?rst place. The Juvenescence team includes highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in the pharmaceutical and consumer health sectors.
Dr. Piizzi has more than 15 years of experience in the global pharmaceutical and biotech industry. Most recently, she was the SVP of Small Molecules R&D and Head of Inflammation at a Flagship Pioneering startup, Cygnal Therapeutics, decoding the links between peripheral neurons and diseases (2019-2021). Previously, she held the position of ....

Novartis Cambridge , Greg Bailey , Grazia Piizzi , Declan Doogan , Jim Mellon , Kostenloser Wertpapierhandel , David Ellam , Merck Cambridge , Juvenescence Ltd , Management Team , Exploratory Science Center , Juvenescence Limited , Executive Management Team , Chief Scientific , Flagship Pioneering , Cygnal Therapeutics , Executive Director , Molecular Invention , நோவர்த்திச் கேம்பிரிட்ஜ் , கிரெக் பெய்லி , டெக்லான் தூகண் , ஜிம் மெலந் , மெர்க் கேம்பிரிட்ஜ் , மேலாண்மை அணி , ஆய்வு அறிவியல் மையம் , நிர்வாகி மேலாண்மை அணி ,

Portage Biotech Divests Portage Pharmaceuticals Limited to Juvenescence Ltd


Portage Biotech Divests Portage Pharmaceuticals Limited to Juvenescence Ltd
Portage may be entitled to up to USD $244 million in future milestone payments -Toronto, Ontario– – Portage Biotech Inc. a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited including subsidiaries Portage Glasgow Ltd. and EyGen Ltd, to Juvenescence Ltd., a company …
Portage may be entitled to up to USD $244 million in future milestone payments –
Toronto, Ontario–(Newsfile Corp. – March 4, 2021) – Portage Biotech Inc. (NASDAQ: PRTG) (CSE: PBT.U) (“Portage” or the “Company”) a clinical stage immuno-oncology company accelerating research and development to overcome immune resistance, today announced the divestment of its three legacy businesses; Portage Pharmaceuticals Limited (PPL), including subsidiaries Portage Glasgow Ltd. ....

Jim Mellon , Declan Doogan , Greg Bailey , Ian Walters , Kate Caruso Sharpe , Chuck Padala , Juvenescence Ltd , Portage Pharmaceuticals Limited , Portage Biotech Inc , Newsfile Corp , Neither The Canadian Securities Exchange , Eygen Ltd , Canadian Securities Exchange , Portage Glasgow Ltd , Portage Biotech , Portage Glasgow , Multilateral Instrument , Minority Security Holders , Special Transactions , Market Regulator , ஜிம் மெலந் , டெக்லான் தூகண் , கிரெக் பெய்லி , ஈயந் வால்டர்ஸ் , கேட் கருசோ கூர்மையான , சக் பாதாள ,